Robeco Institutional Asset Management B.V. Vir Biotechnology, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$51.9 Billion
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$9.14 - $24.62 $378,167 - $1.02 Million	-41,375 Reduced 30.62%	93,752 $878,000
Q1 2023 May 03, 2023	BUY	$22.26 - $30.85 $1.1 Million - $1.53 Million	49,470 Added 57.75%	135,127 $3.14 Million
Q4 2022 Feb 06, 2023	BUY	$19.96 - $28.22 $1.05 Million - $1.49 Million	52,746 Added 160.27%	85,657 $2.17 Million
Q3 2022 Oct 26, 2022	BUY	$18.26 - $31.1 $600,954 - $1.02 Million	32,911 New	32,911 $635,000

Others Institutions Holding VIR

# of Institutions

215

Shares Held

85.8M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$164 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$162 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$129 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$55.4 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$35.2 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.31B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account